Barrington Research Reiterates Integra LifeSciences Outperform, $50 PT - Integra Lifesciences (NASDAQ:IART)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Barrington Research reiterated its Integra LifeSciences (NASDAQ: IART) Outperform rating and $50 price target in a research report published today.In the report, Barrington Research states, "We are reiterating our OUTPERFORM rating and $50 target following IART's Q4/11 results based on the organic and inorganic growth opportunities in each of IART's end markets."Shares of Integra LifeSciences were trading at $31.77 at the time of posting, up 1.92% from Monday's market close.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!